NAVIO - Trademark Details
Status: 731 - Second Extension - Granted
Serial Number
87763013
Word Mark
NAVIO
Status
731 - Second Extension - Granted
Status Date
2022-02-09
Filing Date
2018-01-19
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2020-10-20
Attorney Name
Law Office Assigned Location Code
N20
Employee Name
JOHNSON, DANYTHE ELIZA
Statements
Goods and Services
Pharmaceutical procurement services, namely, purchasing pharmaceuticals for others; pharmaceutical cost management services and drug utilization review services; assisting patients in enrolling in diagnostics and pharmaceutical reimbursement programs of others; providing business, pricing, reimbursement benchmarking and other market intelligence information in the field of drug reimbursement for prescribers, patients and the pharmaceutical industry; providing business, pricing, reimbursement benchmarking and other market intelligence information in the field of diagnostics reimbursement for providers and patients; business administration of diagnostics and pharmacy reimbursement programs and services; business management and consultation services in the field of specialty pharmacy, namely, assisting patients and providers with pharmaceutical reimbursement; business management and consultation services in the field of off label pharmaceuticals, namely, assisting patients and providers with pharmaceutical reimbursement; business management services in the field of diagnostics, namely, assisting patients and providers with diagnostics reimbursement; and promoting collaboration within the scientific, research and medical communities to achieve advances in the fields of healthcare and pharmaceuticals; business management of comprehensive programs involving drug therapy; providing personalized molecular tumor for each patient, namely, treatment services featuring personalized molecular tumors for patients; developing and managing comprehensive treatment programs involving drug therapy, namely, business management of comprehensive treatment programs involving drug therapy
Goods and Services
Pharmaceutical benefit management services; insurance claims processing in the field of diagnostics and pharmaceutical claims; providing a database featuring information and statistics about patient reimbursement and insurance coverage for diagnostics and pharmaceuticals; and reimbursement payment processing in the field of diagnostics and pharmaceutical claims; and providing information in the field of financial support options and resources for prescribers, patients and the pharmaceutical industry; providing patient reimbursement and insurance coverage information in the field of drug reimbursement for prescribers, patients and the pharmaceutical industry; providing patient reimbursement and insurance coverage information in the field of diagnostics reimbursement for providers and patients; financial administration of diagnostics and pharmacy reimbursement programs and services; providing healthcare insurance benefits counseling information in the field of oncology
Goods and Services
Medical, clinical and scientific research in the field of oncology, namely, research relating to genetic diagnostic assays and pharmaceuticals for personalized diagnosis, treatment and prevention of cancer; scientific and technological services, namely, research services for medical purposes in the field of genetic diagnostic assays and pharmaceuticals research for personalized diagnosis, treatment and prevention of cancer; providing medical and scientific research information and scientific consulting in the field of genetic diagnostic assays and pharmaceuticals for diagnosis, treatment and prevention of cancer; conducting early evaluations in the field of new genetic diagnostics assays and pharmaceuticals; development, evaluation and medical and scientific research of genetic diagnostic assays for personalized diagnosis, treatment and prevention of cancer; laboratory research services relating to genetic diagnostic assays for personalized diagnosis, treatment and prevention of cancer; providing medical and scientific research information in the field of genetic diagnostic assays, pharmaceuticals, clinical trials and genetics; technical consulting related to scientific and medical studies in the field of genetic diagnostic assay and pharmaceuticals for personalized diagnosis, treatment and prevention of cancer; basic and clinical research in the field of oncology, namely, researching genetic diagnostic assays and pharmaceuticals for personalized diagnosis, treatment and prevention of cancer; providing medical and scientific research information in the field of genetic diagnostic assays, pharmaceuticals and clinical trials for personalized diagnosis, treatment and prevention of cancer; custom design and development of chemical reagents and multiplex sequencing assays for personalized diagnosis, treatment and prevention of cancer; providing an on-line computer database featuring medical and scientific research information in the field of oncology that allows for input and collection of scientific and research data and information relating to genetic diagnostic assays and pharmaceuticals for diagnosis, treatment and prevention of cancer; data collection for research purposes, namely, data mining and pattern recognition, designing clinical studies, and generating genomic data from patient samples for personalized diagnosis, treatment and prevention of cancer; data collection for research purposes, namely, the collection and systematic sorting of clinical and patient data comprising patient specific clinical data and scientific clinical studies relating to genetic diagnostic assays and pharmaceuticals for personalized diagnosis, treatment and prevention of cancer; data collection for research purposes, namely, the collection of mathematical and statistical data, clinical data, patient data and data of clinical studies relating to clinical response to cancer treatments for personalized diagnosis, treatment and prevention of cancer; compiling data for research purposes in the field of medical science, namely, compiling patient specific molecular and genomic data, patient specific clinical data and scientific clinical studies for personalized diagnosis, treatment and prevention of cancer; providing a website featuring technology with a web-based interface where medical professionals can view genetic test results and interpretations of the results by scientists and medical professionals in the field of genomics, and select the appropriate treatment and order the necessary pharmaceutical products; providing personalized molecular tumor for each patient, namely, providing medical research information regarding personalized molecular tumor treatments; providing medical research and scientific research information in the field of oncology via the Internet; development of a personalized ctDNA (circulating tumor DNA) assay; molecular profiling for scientific research purposes; providing RNA expression analysis for scientific research purposes; providing standard diagnostics and comprehensive diagnostics, namely, oncology patient diagnostic services for scientific research purposes; providing personalized drug screening for oncology patients for medical research purposes; providing real-time therapeutic response monitoring for oncology patients for medical research purposes; providing crowdsourcing platform in the nature of providing online non-downloadable software for obtaining information and input into a take or project by enlisting the services of a large number of people; molecular profiling for providing comprehensive medical treatment programs involving drug therapy for providing medical research; providing a database in the field of oncology and featuring inputting and collection of data and information all for treatment and diagnosis purposes, namely, providing a computer database in the field of oncology for treatment and diagnosis purposes featuring technology that allows users to input and collect data and information
Goods and Services
Medical services in the field of oncology, nephrology; dispensing of pharmaceuticals; medical and pharmaceutical consultation; pharmaceutical advice; pharmaceutical compounding services; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical services, namely, providing personalized drug therapy management programs to cancer patients based on the patient's genetic testing results; genetic testing for medical purposes; genetic testing for cancer diagnosis, treatment and prevention purposes; providing genetic sequencing and consulting services via website designed to provide cancer patients and oncologists with custom tailored information about the range of possible treatments and drug therapies for a particular cancer; providing information to patients and physicians via a website to recommend cancer treatment and drug therapies based on the patient's genetic testing results; providing personalized drug therapy services for cancer patients; drug utilization review dispensing services via a website, namely, identifying cancer drug therapies based on a patient's genetic testing results prior to dispensing medications; developing and managing comprehensive treatment programs involving drug therapy, namely, providing comprehensive medical treatment programs involving drug therapy for the treatment of cancer; physician support services in the nature of providing medical consultation in the dispensing of prescription drugs for persons with particular cancers; providing medical evaluations of patients to determine acceptability for participation in clinical trials; providing healthcare medical counseling, screening, diagnosis, prognosis, treatment, relapse, palliative, integrative medicine, survivorship information, namely, providing comprehensive medical treatment programs involving drug therapy, and other related medical information in the field of oncology; Health care services, namely, providing a database in the field of oncology information and featuring inputting and collection of data and information all for treatment and diagnosis purposes; healthcare consultation in the field of cancer treatment research, namely, advising patients on cancer treatment research studies in which they might participate for purposes of treating their conditions; providing an online searchable database in the fields of oncology, bioinformatics, clinical information technology, genomic data and genomic sequence analysis for personalized diagnosis, treatment and prevention of cancer; molecular profiling for providing comprehensive medical treatment programs involving drug therapy for providing medical treatment; providing RNA expression analysis for medical treatment and diagnosis; providing personalized immunotherapy; Medical services, namely, providing cancer diagnosis; providing standard diagnostics and comprehensive diagnostics, namely, providing standard and comprehensive medical testing for diagnostic purposes; medical services, namely, providing personalized drug screening; providing real-time therapeutic response monitoring for medical treatment and diagnostic purposes; provide individualized expert medical advice and diagnosis in the field of oncology; provide machine learning based medical treatment for cancer patients; providing personalized molecular tumor for each patient, namely, providing medical treatment in the nature of providing personalized molecular tumor for each patient for the treatment of cancer; molecular profiling for oncology treatment purposes; providing RNA expression analysis for oncology treatment purposes; providing standard diagnostics and comprehensive diagnostics, namely, oncology patient diagnostic services for medical treatment purposes; providing personalized drug screening for oncology patients for medical purposes; providing real-time therapeutic response monitoring for oncology patients for medical purposes; providing personalized drug screening for medical treatment and diagnostic purposes; provide machine learning based treatment in the nature of medical treatment and diagnostic purposes for cancer patients
Goods and Services
Physician support services in the nature of providing legal consultation in the dispensing of prescription drugs for persons with particular cancers; providing survivorship information in the field of oncology, namely, legal advice regarding survivorship; provide individualized expert legal advice and diagnosis
Translation of Words in Mark
The English translation of "NAVIO" in the mark is "SHIP".
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2018-01-31
Primary Code
042
International Class
044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2018-01-31
Primary Code
044
International Class
045 - Personal and social services rendered by others to meet the needs of individuals; security services for the protection of property and individuals. - Personal and social services rendered by others to meet the needs of individuals; security services for the protection of property and individuals.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2018-11-08
Primary Code
045
Current Trademark Owners
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Correspondences
Name
Brian R. Coleman
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2018-01-23 | NEW APPLICATION ENTERED IN TRAM |
2018-01-31 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2018-04-30 | ASSIGNED TO EXAMINER |
2018-05-08 | NON-FINAL ACTION WRITTEN |
2018-05-08 | NON-FINAL ACTION E-MAILED |
2018-05-08 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2018-11-07 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2018-11-07 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2018-11-08 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2018-11-29 | SUSPENSION LETTER WRITTEN |
2018-11-29 | LETTER OF SUSPENSION E-MAILED |
2018-11-29 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
2019-06-14 | ASSIGNED TO LIE |
2019-06-19 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
2020-01-24 | SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION |
2020-02-18 | FINAL REFUSAL WRITTEN |
2020-02-18 | FINAL REFUSAL E-MAILED |
2020-02-18 | NOTIFICATION OF FINAL REFUSAL EMAILED |
2020-08-12 | EXPARTE APPEAL RECEIVED AT TTAB |
2020-08-12 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
2020-08-12 | EX PARTE APPEAL-INSTITUTED |
2020-08-12 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
2020-08-15 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2020-08-15 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2020-09-03 | EXAMINERS AMENDMENT -WRITTEN |
2020-09-03 | EXAMINERS AMENDMENT E-MAILED |
2020-09-03 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
2020-09-03 | EXAMINER'S AMENDMENT ENTERED |
2020-09-14 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2020-09-14 | EXPARTE APPEAL TERMINATED |
2020-09-30 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2020-10-20 | PUBLISHED FOR OPPOSITION |
2020-10-20 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2020-11-13 | EXTENSION OF TIME TO OPPOSE RECEIVED |
2020-12-30 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
2021-02-09 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
2021-08-05 | TEAS EXTENSION RECEIVED |
2021-08-05 | EXTENSION 1 FILED |
2021-08-05 | EXTENSION 1 GRANTED |
2021-08-07 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2022-02-09 | TEAS EXTENSION RECEIVED |
2022-02-09 | EXTENSION 2 FILED |
2022-02-09 | EXTENSION 2 GRANTED |
2022-02-11 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |